FREE DOWNLOAD In their annual wrap-up, Prescrire's editors conclude that while France is better focused on patients' interests after the Mediator° scandal, there is stagnation elsewhere.The feature includes a too-long list of drugs with more harms than benefits that are still on the market in France. And sums up the timid progress made in France's new drugs policy initiative.
Full text available for free download.